Provides refundable tax credits to Canadian-controlled private corporations for healthcare R&D expenditures including salaries, materials, subcontractor costs, and capital equipment used 90% or more for R&D. Eligible activities include novel assays, medical devices, therapeutics, diagnostic algorithms, and biomanufacturing process innovation. Enhanced 35% credit applies up to $6 million in expenditures, with combined provincial credits reaching about 65% recovery.
Eligible applicants are Canadian-controlled private corporations conducting qualifying healthcare R&D activities. Claims must be filed within 18 months of fiscal year-end.
